GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » 3-Year Revenue Growth Rate

Renalytix (LSE:RENX) 3-Year Revenue Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Renalytix 3-Year Revenue Growth Rate?

Renalytix's Revenue per Share for the three months ended in Mar. 2024 was £0.00.

During the past 12 months, Renalytix's average Revenue per Share Growth Rate was -55.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Renalytix's 3-Year Revenue Growth Rate

For the Health Information Services subindustry, Renalytix's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renalytix's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Renalytix's 3-Year Revenue Growth Rate falls into.



Renalytix 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Renalytix  (LSE:RENX) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Renalytix 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Renalytix's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Renalytix (LSE:RENX) Business Description

Traded in Other Exchanges
Address
5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex 12-14-2012

Investing in Information

By Vanina Egea Vanina Egea 03-06-2014

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe 08-29-2013